Examining procedures to reduce communication breakdowns

Researchers have developed a set of structured tools to decrease medical communication errors during multidisciplinary morning rounds in the hospital.

Reported in Journal of Medical Internet Research Human Factors, the research centered on test rounding tools that improve effeciency and quality of care. While previous studies have shown that daily meetings between clinicians can improve patient care and outcomes, this study focused on the 70 percent of deaths caused by medical errors in the communication during patient handoffs.

The structured rounding tools were meant to "evaluate if they improved equality in time allocation across patients and quality of patient care team communication," said Joanna Abraham, assistant professor of biomedical and health information sciences at University of Illinois at Chicago.

Some 82 patient cases were audio recorded, analyzed for the time spent discussing the patient and coded for communication breakdowns. Results showed that time spent per patient improved with the use of the tool and that communication breakdowns increased with the amount of time spent discussing each patient.

"This study shows that the use of structured rounding tools mitigates disproportionate time allocation and communication breakdowns during rounds," said Abraham. "With the more structured HAND-IT tool, these effects were almost completely eliminated. Our results help to demonstrate the benefits of using structured rounding tools for reducing communication errors and improving patient care quality and safety. Although our results are preliminary, they present a strong case for further research into rounding communication.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.